miR-140 ameliorates neuropathic pain in CCI rats by targeting S1PR1

References

• Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain. 2011;152(10):2204–2205.
   PubMed Web of Science ®Google Scholar
• Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635.
   PubMed Web of Science ®Google Scholar
• Bick SKB, Eskandar EN. Surgical treatment of trigeminal neuralgia. Neurosurg Clin N Am. 2017;28(3):429–438.
   PubMed Web of Science ®Google Scholar
• Xiaojuan Wu YW, Sun Z, Ren S, et al. Molecular expression and functional analysis of genes in children with temporal lobe epilepsy. J Integr Neurosci. 2019;18(1):71–77.
   PubMed Web of Science ®Google Scholar
• Sakai A, Suzuki H. Emerging roles of microRNAs in chronic pain. Neurochem Int. 2014;77:58–67.
   PubMed Web of Science ®Google Scholar
• Favereaux A, Thoumine O, Bouali-Benazzouz R, et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. Embo J. 2011;30(18):3830–3841.
   PubMed Web of Science ®Google Scholar
• Shi G, Shi J, Liu K, et al. Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia. 2013;61(4):504–512.
   PubMed Web of Science ®Google Scholar
• Yan T, Zhang F, Sun C, et al. miR-32-5p-mediated Dusp5 downregulation contributes to neuropathic pain. Biochem Biophys Res Commun. 2018;495(1):506–511.
   PubMed Web of Science ®Google Scholar
• Shi J, Jiang K, Li Z. MiR-145 ameliorates neuropathic pain via inhibiting inflammatory responses and mTOR signaling pathway by targeting Akt3 in a rat model. Neurosci Res. 2018;134:10–17.
   PubMed Web of Science ®Google Scholar
• Tu Z, Li Y, Dai Y, et al. MiR-140/BDNF axis regulates normal human astrocyte proliferation and LPS-induced IL-6 and TNF-α secretion. Biomed Pharmacother. 2017;91:899–905.
   PubMed Web of Science ®Google Scholar
• Huang W, Li MD. Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol. 2009;12(4):537–546.
   PubMed Web of Science ®Google Scholar
• Rosen H, Goetzl EJ. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol. 2005;5(7):560–570.
   PubMed Web of Science ®Google Scholar
• Grenald SA, Doyle TM, Zhang H, et al. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. Pain. 2017;158(9):1733–1742.
   PubMed Web of Science ®Google Scholar
• Janes K, Little JW, Li C, et al. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. J Biol Chem. 2014;289(30):21082–21097.
   PubMed Web of Science ®Google Scholar
• Stockstill K, Doyle TM, Yan X, et al. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain. J Exp Med. 2018;215(5):1301–1313.
   PubMed Web of Science ®Google Scholar
• Tan PH, Pao YY, Cheng JK, et al. MicroRNA-based therapy in pain medicine: Current progress and future prospects. Acta Anaesthesiol Taiwan. 2013;51(4):171–176.
   PubMedGoogle Scholar
• Asano M, Umezu T, Katagiri S, et al. Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors. Int J Hematol. 2017;105(4):419–422.
   PubMed Web of Science ®Google Scholar
• Hsu HC, Tang NY, Lin YW, et al. Effect of electroacupuncture on rats with chronic constriction injury-induced neuropathic pain. ScientificWorldJournal. 2014;2014:129875
   PubMedGoogle Scholar
• Jiangpan P, Qingsheng M, Zhiwen Y, et al. Emerging role of microRNA in neuropathic pain. Curr Drug Metab. 2016;17(4):336–344.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mou J, Cao L, et al. MicroRNA-142-3p relieves neuropathic pain by targeting high mobility group box 1. Int J Mol Med. 2017;41(1):501–510.
   PubMed Web of Science ®Google Scholar
• Arruri V, Komirishetty P, Areti A, et al. Nrf2 and NF-κB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain. Pharmacol Rep. 2017;69(4):625–632.
   PubMed Web of Science ®Google Scholar
• Xie XJ, Ma LG, Xi K, et al. Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain. Mol Pain. 2017;13:1744806917706582.
   Web of Science ®Google Scholar
• Liu F, Wang Z, Qiu Y, et al. Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat. J Neuroinflammation. 2017;14(1):70.
   PubMedGoogle Scholar
• Yin Y, Sui C, Meng F, et al. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway. Lipids Health Dis. 2017;16(1):87
   PubMedGoogle Scholar
• Zhang J, Yin J, Chen X, et al. Down-regulation of miR-140-3p can alleviate neonatal repetitive pain in rats via inhibiting TGF-β3. Biochem Biophys Res Commun. 2019;515(4):627–635.
   PubMed Web of Science ®Google Scholar
• Xie W, Strong JA, Kays J, et al. Knockdown of the sphingosine-1-phosphate receptor S1PR1 reduces pain behaviors induced by local inflammation of the rat sensory ganglion. Neurosci Lett. 2012;515(1):61–65.
   PubMed Web of Science ®Google Scholar
• Chen Z, Doyle TM, Luongo L, et al. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. Proc Natl Acad Sci USA. 2019;116(21):10557–10562.
   PubMed Web of Science ®Google Scholar
• Liang J, Nagahashi M, Kim EY, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107–120.
   PubMed Web of Science ®Google Scholar
• Lee H, Deng J, Kujawski M, et al. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med. 2010;16(12):1421–1428.
   PubMed Web of Science ®Google Scholar
• Yan X-T, Ji L-J, Wang Z, et al. MicroRNA-93 alleviates neuropathic pain through targeting signal transducer and activator of transcription 3. Int Immunopharmacol. 2017;46:156–162.
   PubMed Web of Science ®Google Scholar